1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid has been researched along with Fibrosarcoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amirdhanayagam, J; Das, T; Dash, A; Guleria, M; Sarma, HD | 1 |
| Banerjee, S; Bhadwal, M; Chakravarty, R; Das, T; Dash, A; Mittal, S; Pillai, MR; Sarma, HD | 1 |
2 other study(ies) available for 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid and Fibrosarcoma
| Article | Year |
|---|---|
Comparative Evaluation of Using NOTA and DOTA Derivatives as Bifunctional Chelating Agents in the Preparation of
Topics: Animals; Cell Line, Tumor; Chelating Agents; Disease Models, Animal; Fibrosarcoma; Gallium Radioisotopes; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Mice; Porphyrins; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Distribution | 2018 |
Synthesis and biological evaluation of 90Y-labeled porphyrin-DOTA conjugate: a potential molecule for targeted tumor therapy.
Topics: Animals; Female; Fibrosarcoma; Heterocyclic Compounds, 1-Ring; Kidney; Mice; Porphyrins; Radioisotopes; Radiopharmaceuticals; Radiotherapy; Spectroscopy, Fourier Transform Infrared; Strontium Radioisotopes; Time Factors; Tissue Distribution; Yttrium Radioisotopes | 2013 |